ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
ChemoCentryx Inc

ChemoCentryx Inc (CCXI)

51.99
0.00
(0.00%)
Closed December 28 4:00PM
0.00
0.00
(0.00%)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
51.99
Bid
30.00
Ask
51.92
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
51.99
Open
-
Last Trade
Last Trade Time
Average Volume (3m)
-
Financial Volume
-
VWAP
-

CCXI Latest News

AMGEN SUCCESSFULLY COMPLETES ACQUISITION OF CHEMOCENTRYX

AMGEN SUCCESSFULLY COMPLETES ACQUISITION OF CHEMOCENTRYX PR Newswire THOUSAND OAKS, Calif., Oct. 20, 2022 TAVNEOS® (avacopan), a First-in-Class Medicine for Patients With Severe Active...

ChemoCentryx Announces Presentations at the 2022 American Society of Nephrology and American College of Rheumatology Annual Meetings

-- Planned posters and an oral presentation will highlight data from the trials that supported the approval of TAVNEOS® (avacopan) for patients with ANCA-associated vasculitis; additional poster...

ChemoCentryx Announces Upcoming Presentations for Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting

-- Two poster presentations planned for CCX559, including results from ongoing Phase I clinical study in patients with advanced solid tumors, and preclinical evidence from murine model -- SAN...

ChemoCentryx Announces TAVNEOS® (avacopan) Presentations at Upcoming Medical Conferences

SAN CARLOS, Calif., Aug. 24, 2022 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced planned poster presentations at three upcoming medical conferences taking place in...

ChemoCentryx Cancels Second Quarter 2022 Financial Results Conference Call

SAN CARLOS, Calif., Aug. 09, 2022 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced the cancellation of its second quarter 2022 financial results conference call scheduled...

ChemoCentryx Shares Soar Premarket on Amgen Takeover Deal

By Colin Kellaher Shares of ChemoCentryx Inc. took flight in premarket trading Thursday after the biotechology company agreed to be acquired by larger peer Amgen Inc. for $3.7 billion in cash...

AMGEN TO ACQUIRE CHEMOCENTRYX FOR $4 BILLION IN CASH

AMGEN TO ACQUIRE CHEMOCENTRYX FOR $4 BILLION IN CASH PR Newswire THOUSAND OAKS, Calif. and SAN CARLOS, Calif., Aug. 4, 2022 Acquisition Includes TAVNEOS® (avacopan), a First-in-Class Medicine for...

ChemoCentryx to Hold Second Quarter 2022 Financial Results Conference Call on Tuesday, August 9, 2022

SAN CARLOS, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that the Company's second quarter 2022 financial results will be released after market...

ChemoCentryx Announces Appointment of Jennifer L. Herron to Board as Independent Director

SAN CARLOS, Calif., July 05, 2022 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Jennifer L. Herron has been appointed to the Board as an independent director...

ChemoCentryx Reports Safety Results Available from Ongoing Phase I Trial of Orally Administered PD-L1 Inhibitor, CCX559, at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting

-- Consistent with approved antibody inhibitors of PD-L1, CCX559 demonstrates immunomodulatory activity in first cycle of treatment -- -- Safety and tolerability allow for continued dose...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

CCXI - Frequently Asked Questions (FAQ)

What is the current ChemoCentryx share price?
The current share price of ChemoCentryx is $ 51.99
What is the 1 year trading range for ChemoCentryx share price?
ChemoCentryx has traded in the range of $ 0.00 to $ 0.00 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
INTZIntrusion Inc
$ 2.167
(381.56%)
189.59M
AILEiLearningEngines Inc
$ 0.5932
(267.31%)
563.26M
HUBCWHub Cyber Security Ltd
$ 0.035
(250.00%)
2.79M
GTIGraphjet Technology
$ 0.967551
(185.83%)
398.95M
LITMSnow Lake Resources Ltd
$ 1.61
(82.95%)
131.98M
NEUPNeuphoria Therapeutics Inc
$ 4.11
(-92.30%)
940.73k
VIRXViracta Therapeutics Inc
$ 0.16
(-32.49%)
9.47M
PRFXPainReform Ltd
$ 3.48
(-28.98%)
949.52k
AIREreAlpha Tech Corporation
$ 2.56
(-28.49%)
8.42M
AVGRAvinger Inc
$ 0.9721
(-24.05%)
2.16M
AILEiLearningEngines Inc
$ 0.5932
(267.31%)
563.26M
GTIGraphjet Technology
$ 0.967551
(185.83%)
398.95M
RGTIRigetti Computing Inc
$ 17.08
(10.62%)
305.79M
XTIAXTI Aerospace Inc
$ 0.03935
(-1.63%)
268M
QSIQuantum Si Inc
$ 3.585
(66.74%)
256.01M

CCXI Discussion

View Posts
bbartgen bbartgen 3 years ago
I have some in family ties. I can’t pm.
👍️0
jsc52033 jsc52033 3 years ago
Thanks for the PM you sent about the other stock I hold. I don't have PM privalege but can you please send me the document you mentioned.
👍️0
jsc52033 jsc52033 3 years ago
sorry I can't respond via prive emailto your question I droped down but continu to hold a reminder possition.
I believe it has a greta furtre but this is a bear market and most boats sink so went into much safer plays with solid divs.
👍️0
jgrabar jgrabar 3 years ago





Current ChemoCentryx, Inc. shareholders who have held shares of the Company’s stock since at least November 26, 2019, can seek corporate reforms, the return of funds back to company coffers and potentially a court approved incentive award if appropriate.

The underlying class action complaint alleges that the defendants misrepresented and/or failed to disclose to investors that: (1) the study design of the Phase III ADVOCATE drug trial presented issues about the interpretability of the trial data to define a clinically meaningful benefit of avacopan and its role in the management of AAV; (2) the data from the Phase III ADVOCATE trial raised serious safety concerns for avacopan; (3) these issues presented a substantial concern regarding the viability of ChemoCentryx’s NDA for avacopan for the treatment of ANCA-associated vasculitis; and (4) as a result of the foregoing, the defendants’ public statements were materially false and misleading at all relevant times.

If you would like to learn more about this matter at no cost to you, please fill out the form provided or contact us at jgrabar@grabarlaw.com or call 267-507-6085.

https://grabarlaw.com/the-latest/chemocntryx-investigation/

👍️0
ok2buy ok2buy 3 years ago
Moving back up today in late afternoon trading. Could be a rocket tomorrow./ok2
👍️0
Worthwalk Worthwalk 3 years ago
This thing is obliterating. Where is the bottom any thoughts?
👍️0
ok2buy ok2buy 3 years ago
Strong run at the end of the day. Would like to see the intraday high challenged. Perhaps the buying here is in advance of some additional news. I like what I am seeing here. Best of luck to the longs./ok2
👍️0
ok2buy ok2buy 3 years ago
Just announced, Amber Specialty Pharma to begin dispensing TAVNEOS for the company. I guess my question, Is CCXI a buyout target for a larger pharma company? If so, that would certainly support SVB Leerink's PT which they updated on Oct. 11 from $17 to $64/share. Best of luck to the longs./ok2
👍️0
Limey42 Limey42 3 years ago
No surprise with the offering......time to hoover some cheapies!
👍️0
Mikey Mikey 3 years ago
took $600 hit on this dog with fleas


......................./??/)
....................../?../
....................,/?../
.................../..../
............./??/'...'/???`·?
........../'/.../..../......./??\
........('(...?...?.... ?~/'...')
.........\.................'...../
..........''...\.......... _.·?
............\..............(
..............\.............\....
👍️0
Mikey Mikey 3 years ago
well hey bud.........I knew eventually we would agree on something!
👍️0
PickleNick PickleNick 3 years ago
Bloated? Lol do you even know what the SS is?
👍️0
pepeoil pepeoil 3 years ago
Yep, bailed on this bloated pig. Hit a good lick here though
👍️0
Cosa Cosa 3 years ago
I'm out of here guys! good luck!
👍️0
Mikey Mikey 3 years ago
back in CCXI $40 calls expire friday....$2.22 avg......did not catch a bottom, but we'll take it
👍️0
rynlrt rynlrt 3 years ago
I just started learning them. Actually seems like an easier way to make money faster. Just a bit of a higher risk
👍️0
rynlrt rynlrt 3 years ago
Guarantee next week they do an offering to help with all of that debt
👍️0
newdmontheblock newdmontheblock 3 years ago
Is that drop based on any TA? IMO we could see a drop Monday as penny flippers take profits but this is a mid-long term hold for some serious gains. 2 new revenue streams open with EU approval not far off most likely. Add in $400MM in cash on hand, no competition in this space for at least 5 years, and other drugs in the pipeline and it’s not hard to imagine CCXI running close to $100 by this time next year or sooner IMO. Bear case is an offering but don’t see CCXI needing to do that now that they have solid market opportunity in front of them.

Full disclosure: 623 shares at $18.90 so you best bet I’m a happy camper today!
👍️0
Jake L Jake L 3 years ago
CCXI - Friday Rundown, Monday Expectations

👍️0
Cosa Cosa 3 years ago
This post aged well!
👍️0
Cosa Cosa 3 years ago
Cheers!
👍️0
BoilerRoom BoilerRoom 3 years ago
Nice work!
👍️0
BoilerRoom BoilerRoom 3 years ago
I need to learn options. Sound fun
👍️0
mikebennett16 mikebennett16 3 years ago
Got a short position?:)
👍️0
BottomBounce BottomBounce 3 years ago
$CCXI Debt $71.7M
👍️0
jonnyvs jonnyvs 3 years ago
Up or down the last 30 minutes? Fear of an AH offering I think will be on the mind of some. Pretty strong recovery though off that dip
👍️0
crudeoil24 crudeoil24 3 years ago
Great video to end our trading session. Enjoy the weekend!
👍️0
Mikey Mikey 3 years ago
lol.......
👍️0
Mikey Mikey 3 years ago
ALL OUT .90, 1.00, 1.10.......from .30.....didnt maximize, but we'll take it

👍️0
Mikey Mikey 3 years ago
I might........up quite a bit, eh?
👍️0
Nebuchadnezzar Nebuchadnezzar 3 years ago
take profits before this tanks $3-$8 on Monday
👍️0
crudeoil24 crudeoil24 3 years ago
40.54
👍️0
Mikey Mikey 3 years ago
LOL, Missed the big pop, and wasnt really excited about it, so I picked up a few $50calls........HUNU


Filled Buy to Open 15 CHEMOCENTRYX INC CALL October 50 Limit 0.30 -- -- 13:03:35 10/08/21





👍️0
crudeoil24 crudeoil24 3 years ago
THIS LOW FLOAT > STAIRWAY TO HEAVEN!

CCXI
👍️0
crudeoil24 crudeoil24 3 years ago
38.17 > hod
👍️0
Jess070283 Jess070283 3 years ago
$100+ price target!$$$
👍️0
mikebennett16 mikebennett16 3 years ago
Lol, don't say that ??
👍️0
rynlrt rynlrt 3 years ago
Probably gonna be an offering after hours
👍️0
pepeoil pepeoil 3 years ago
Lol. Got me 1200 shares of this beauty
👍️0
pepeoil pepeoil 3 years ago
Chee chee chee home run here boys
👍️0
crudeoil24 crudeoil24 3 years ago
53M trading float!

CCXI
👍️0
crudeoil24 crudeoil24 3 years ago
MASSIVE NEWS > WHAT A $WEET RUNNNNN!


CCXI
👍️0
pepeoil pepeoil 3 years ago
Time to make bank today boys, toooooo daaaaaa mooooooon
👍️0
Limey42 Limey42 3 years ago
Well played boys and girls, a glorious day!
👍️0
newdmontheblock newdmontheblock 3 years ago
Just re-allocated from AMC to here! Japan approving Avacopan helps FDA approval bigly. One CC out for Oct. 15th at $25 strike and holding around 500 shares for October 7th results. Hoping for $50+!
👍️0
Limey42 Limey42 3 years ago
Great news today....now it's up to the FDA next. GL all.
👍️0
newdmontheblock newdmontheblock 3 years ago
Anything that sends us north is fine by me! CRL is unlikely IMO and even if it did happen, I believe it’s already priced in. We’ll see though! Happy 4th if you’re in the USA!
👍️0
chance4 chance4 3 years ago
I'm thinking we probably get a CONDITIONAL APPROVAL!! Which is still gonna move this NORTH!!! All IMHO....
👍️0
newdmontheblock newdmontheblock 3 years ago
AH looked strong today. Hoping to see some FOMO buying rush in Tuesday followed by approval Wednesday!
👍️0
newdmontheblock newdmontheblock 4 years ago
Good luck to you as well!
👍️0

Your Recent History

Delayed Upgrade Clock